secwatch / observer
8-K filed October 10, 2023, 7:59 PM ET ticker TLPH CIK 0001427925
other material confidence high sentiment neutral materiality 0.35

AcelRx shareholders approve 1.5M share increase to 2020 equity plan; elect three directors

TALPHERA, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Approval of amendment and restatement of the Amended and Restated 2020 Equity Incentive Plan at the 2023-10-10 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Proposal No. 4 The Company’s Amended and Restated 2020 Equity Incentive Plan was approved, by the following vote: For Against Abstain 6,562,640 486,414 35,579
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Advisory vote on executive compensation at the 2023-10-10 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Proposal No. 3 The compensation paid to the Company’s named executive officers
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Election of Class III Directors at the 2023-10-10 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Nominee For Withheld Marina Bozilenko 6,746,727 337,906 Howard B. Rosen 6,691,709 392,924 Mark Wan 6,724,271 360,362
View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

TALPHERA, INC. filing history →

Source: SEC EDGAR
accession 0001437749-23-027971
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.